![](/img/cover-not-exists.png)
736POverall survival of patients with hepatocellular carcinoma receiving sorafenib versus selective internal radiation therapy with predicted osimetry in the SARAH trial
Hawkins, N S, Ross, P J, Palmer, D H, Chatellier, G, Pereira, H, Vilgrain, VVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.063
Date:
October, 2019
File:
PDF, 75 KB
2019